🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Elevated aldosterone causes moderate to severe increase in blood pressure, ...
Status
Enrolling By Invitation
Location
Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region
Start Date
2023-04-16
Trial ID
NCT05688579
Treatments Being Tested
This study aims to investigate the efficacy and safety of exercise rehabili...
Status
Recruiting
Location
The Affiliated Hospital of Nantong University
Start Date
2025-09-15
Trial ID
NCT07167368
Rationale: Primary hyperaldosteronism (PA) is the most frequent form of sec...
Status
Completed
Location
UMC St. radboud
Start Date
2010-07
Trial ID
NCT01096654
Treatments Being Tested
The study aims to investigate the efficacy and safety of the early initiati...
Status
Completed
Location
National heart institute
Start Date
2022-06-04
Trial ID
NCT05364190
Treatments Being Tested
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown further reduct...
Status
Unknown
Location
University of Florida
Start Date
2023-12-27
Trial ID
NCT06201000
Treatments Being Tested
The goal of this observational study is to learn more about kidney health i...
Status
Recruiting
Location
Penn Presbyterian Medical Center
Start Date
2025-11-12
Trial ID
NCT07444203
This study aims to further develop an imaging-guided cohort of rare cardiom...
Status
Not Yet Recruiting
Location
Renji Hospital
Start Date
2025-02-01
Trial ID
NCT06794710
This is a multicenter, observational, prospective, national study which inc...
Status
Completed
Location
Research Site
Start Date
2024-02-09
Trial ID
NCT06185660
Treatments Being Tested
The primary objective of this study is to determine if a best practice aler...
Status
Completed
Location
Cardiology/Internal Medicine Outpatient Clinics of Yale New Health System
Start Date
2021-11-03
Trial ID
NCT04903717
Treatments Being Tested